Isotope labeled internal standards (ILIS) as a basis for quality control in clinical studies using plasma samples

Journal of Proteomics

Volumn 73, Issue 6, 2010, Pages 1219-1229

  Rezeli, Melinda ^a   Végvári, Ákos ^a   Marko Varga, György ^a   Laurell, Thomas ^a  

^a LUND UNIVERSITY   (Sweden)

Author keywords

Clinical proteomics; Heavy isotope labeled peptides; Human blood plasma; Mass spectrometry

Indexed keywords

AMINO ACID; SYNTHETIC PEPTIDE; ISOTOPE; PEPTIDE; PLASMA PROTEIN; PROTEOME;

ADULT; ARTICLE; BIOLOGICAL MONITORING; BLOOD ANALYSIS; BLOOD SAMPLING; BLOOD STORAGE; CONTROLLED STUDY; ELECTROSPRAY MASS SPECTROMETRY; FEMALE; HUMAN; ISOTOPE LABELING; LIQUID CHROMATOGRAPHY; MALE; NORMAL HUMAN; PLASMA; PRIORITY JOURNAL; PROCESS OPTIMIZATION; PROTEIN DEGRADATION; PROTEIN STABILITY; QUALITY CONTROL; ROOM TEMPERATURE; STANDARD; STORAGE TEMPERATURE; THERMOSTABILITY; CALIBRATION; CHEMISTRY; MASS SPECTROMETRY; MEDICAL RESEARCH; METABOLISM; PROCEDURES; PROTEOMICS; STANDARDS; TEMPERATURE; TIME;

BIOMEDICAL RESEARCH; BLOOD PROTEINS; CALIBRATION; HUMANS; ISOTOPE LABELING; ISOTOPES; PEPTIDES; PLASMA; PROTEOME; PROTEOMICS; QUALITY CONTROL; SPECTROMETRY, MASS, ELECTROSPRAY IONIZATION; SPECTROMETRY, MASS, MATRIX-ASSISTED LASER DESORPTION-IONIZATION; TEMPERATURE; TIME FACTORS;

EID: 77950516712     PISSN: 18743919     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jprot.2010.02.012     Document Type: Article

References (42)

1. Anderson N.L., and Anderson N.G. The human plasma proteome - history, character, and diagnostic prospects. Mol Cell Proteomics 1 (2002) 845-867
2. Omenn G.S., States D.J., Adamski M., Blackwell T.W., Menon R., Hermjakob H., et al. Overview of the HUPO plasma proteome project: results from the pilot phase with 35 collaborating laboratories and multiple analytical groups, generating a core dataset of 3020 proteins and a publicly-available database. Proteomics 5 (2005) 3226-3245
3. Faca V., Pitteri S.J., Newcomb L., Glukhova V., Phanstiel D., Krasnoselsky A., et al. Contribution of protein fractionation to depth of analysis of the serum and plasma proteomes. J Proteome Res 6 (2007) 3558-3565
4. Metz T.O., Qian W.J., Jacobs J.M., Gritsenko M.A., Moore R.J., Polpitiya A.D., et al. Application of proteomics in the discovery of candidate protein biomarkers in a diabetes autoantibody standardization program sample subset. J Proteome Res 7 (2008) 698-707
5. Sutton J., Richmond T., Shi X., Athanas M., Ptak C., Gerszten R., et al. Performance characteristics of an FT MS-based workflow for label-free differential MS analysis of human plasma: standards, reproducibility, targeted feature investigation, and application to a model of controlled myocardial infarction. Proteom Clin Appl 2 (2008) 862-881
6. Shen Y.F., Kim J., Strittmatter E.F., Jacobs J.M., Camp D.G., Fang R.H., et al. Characterization of the human blood plasma proteome. Proteomics 5 (2005) 4034-4045
7. Nicol G.R., Han M., Kim J., Birse C.E., Brand E., Nguyen A., et al. Use of an immunoaffinity-mass spectrometry-based approach for the quantification of protein biomarkers from serum samples of lung cancer patients. Mol Cell Proteomics 7 (2008) 1974-1982
8. Pan S., Aebersold R., Chen R., Rush J., Goodlett D.R., McIntosh M.W., et al. Mass spectrometry based targeted protein quantification: methods and applications. J Proteome Res 8 (2009) 787-797
9. Anderson L., and Hunter C.L. Quantitative mass spectrometric multiple reaction monitoring assays for major plasma proteins. Mol Cell Proteomics 5 (2006) 573-588
10. Kuzyk M.A., Smith D., Yang J.C., Cross T.J., Jackson A.M., Hardie D.B., et al. Multiple reaction monitoring-based, multiplexed, absolute quantitation of 45 proteins in human plasma. Mol Cell Proteomics 8 (2009) 1860-1877
11. Villanueva J., Nazarian A., Lawlor K., Yi S.S., Robbins R.J., and Temps P. A sequence-specific exopeptidase activity test (SSEAT) for "functional" biomarker discovery. Mol Cell Proteomics 7 (2008) 509-518
12. Callesen A.K., Vach W., Jorgensen P.E., Cold S., Tan Q., Christensen R.D., et al. Combined experimental and statistical strategy for mass spectrometry based serum protein profiling for diagnosis of breast cancer: a case-control study. J Proteome Res 7 (2008) 1419-1426
13. Villanueva J., Shaffer D.R., Philip J., Chaparro C.A., Erdjument-Bromage H., Olshen A.B., et al. Differential exoprotease activities confer tumor-specific serum peptidome patterns. J Clin Invest 116 (2006) 271-284
14. Ueda K., Katagiri T., Shimada T., Irie S., Sato T.A., Nakamura Y., et al. Comparative profiling of serum glycoproteome by sequential purification of glycoproteins and 2-nitrobenzenesulfenyl (NBS) stable isotope labeling: a new approach for the novel biomarker discovery for cancer. J Proteome Res 6 (2007) 3475-3483
15. Marshall J., Kupchak P., Zhu W.M., Yantha J., Vrees T., Furesz S., et al. Processing of serum proteins underlies the mass spectral fingerprinting of myocardial infarction. J Proteome Res 2 (2003) 361-372
16. Albrethsen J., Kaas A., Schonle E., Swift P., Kocova M., Gammeltoft S., et al. Evaluation of a type 1 diabetes serum cohort by SELDI-TOF MS protein profiling. Proteom Clin Appl 3 (2009) 383-393
17. Diamandis E.P. Peptidomics for cancer diagnosis: present and future. J Proteome Res 5 (2006) 2079-2082
18. Banks R.E. Preanalytical influences in clinical proteomic studies: raising awareness of fundamental issues in sample banking. Clin Chem 54 (2008) 6-7
19. McLerran D., Grizzle W.E., Feng Z.D., Thompson I.M., Bigbee W.L., Cazares L.H., et al. SELDI-TOF MS whole serum proteomic profiling with IMAC surface does not reliably detect prostate cancer. Clin Chem 54 (2008) 53-60
20. Schrohl A.S., Wurtz S., Kohn E., Banks R.E., Nielsen H.J., Sweep F., et al. Banking of biological fluids for studies of disease-associated protein biomarkers. Mol Cell Proteomics 7 (2008) 2061-2066
21. Rai A.J., Gelfand C.A., Haywood B.C., Warunek D.J., Yi J.Z., Schuchard M.D., et al. HUPO plasma proteome project specimen collection and handling: towards the standardization of parameters for plasma proteome samples. Proteomics 5 (2005) 3262-3277
22. Peakman T.C., and Elliott P. The UK Biobank sample handling and storage validation studies. Int J Epidemiol 37 (2008) 2-6
23. Tammen H., Schulte I., Hess R., Menzel C., Kellmann M., and Schulz-Knappe P. Prerequisites for peptidomic analysis of blood samples: I. Evaluation of blood specimen qualities and determination of technical performance characteristics. Comb Chem High T Scr 8 (2005) 725-733
24. Banks R.E., Stanley A.J., Cairns D.A., Barrett J.H., Clarke P., Thompson D., et al. Influences of blood sample processing on low-molecular-weight proteome identified by surface-enhanced laser desorption/ionization mass spectrometry. Clin Chem 51 (2005) 1637-1649
25. Rouy D., Ernens I., Jeanty C., and Wagner D.R. Plasma storage at - 80 degrees C does not protect matrix metalloproteinase-9 from degradation. Anal Biochem 338 (2005) 294-298
26. Elliott P., Peakman T.C., and Biobank U.K. The UK Biobank sample handling and storage protocol for the collection, processing and archiving of human blood and urine. Int J Epidemiol 37 (2008) 234-244
27. Brun V., Masselon C., Garin J., and Dupuis A. Isotope dilution strategies for absolute quantitative proteomics. J Proteomics 72 (2009) 740-749
28. Yi J.Z., Liu Z.X., Craft D., O'Mullan P., Ju G., and Gelfand C.A. Intrinsic Peptidase Activity Causes a Sequential Multi-Step Reaction (SMSR) in digestion of human plasma peptides. J Proteome Res 7 (2008) 5112-5118
29. Zheng X.Y., Baker H., and Hancock W.S. Analysis of the low molecular weight serum peptidome using ultrafiltration and a hybrid ion trap-Fourier transform mass spectrometer. J Chromatogr A 1120 (2006) 173-184
30. Tammen H., Schulte L., Hess R., Menzel C., Kellmann M., Mohring T., et al. Peptidomic analysis of human blood specimens: comparison between plasma specimens and serum by differential peptide display. Proteomics 5 (2005) 3414-3422
31. Koomen J.M., Li D.H., Xiao L.C., Liu T.C., Coombes K.R., Abbruzzese J., et al. Direct tandem mass spectrometry reveals limitations in protein profiling experiments for plasma biomarker discovery. J Proteome Res 4 (2005) 972-981
32. Aristoteli L.P., Molloy M.P., and Baker M.S. Evaluation of endogenous plasma peptide extraction methods for mass spectrometric biomarker discovery. J Proteome Res 6 (2007) 571-581
33. Chertov O., Biragyn A., Kwak L.W., Simpson J.T., Boronina T., Hoang V.M., et al. Organic solvent extraction of proteins and peptides from serum as an effective sample preparation for detection and identification of biomarkers by mass spectrometry. Proteomics 4 (2004) 1195-1203
34. Orvisky E., Drake S.K., Martin B.M., Abdel-Hamid M., Ressom H.W., Varghese R.S., et al. Enrichment of low molecular weight fraction of serum for MS analysis of peptides associated with hepatocellular carcinoma. Proteomics 6 (2006) 2895-2902
35. Callesen A.K., Madsen J.S., Vach W., Kruse T.A., Mogensen O., and Jensen O.N. Serum protein profiling by solid phase extraction and mass spectrometry: a future diagnostics tool?. Proteomics 9 (2009) 1428-1441
36. Berven F.S., Kroksveen A.C., Berle M., Rajalahti T., Flikka K., Arneberg R., et al. Pre-analytical influence on the low molecular weight cerebrospinal fluid proteome. Proteom Clin Appl 1 (2007) 699-711
37. Larsen M.R., Cordwell S.J., and Roepstorff P. Graphite powder as an alternative or supplement to reversed-phase material for desalting and concentration of peptide mixtures prior to matrix-assisted laser desorption/ionization-mass spectrometry. Proteomics 2 (2002) 1277-1287
38. Villanueva J., Philip J., Entenberg D., Chaparro C.A., Tanwar M.K., Holland E.C., et al. Serum peptide profiling by magnetic particle-assisted, automated sample processing and MALDI-TOF mass spectrometry. Anal Chem 76 (2004) 1560-1570
39. Villanueva J., Lawlor K., Toledo-Crow R., and Tempst P. Automated serum peptide profiling. Nat Protocols 1 (2006) 880-891
40. Hsieh S.Y., Chen R.K., Pan Y.H., and Lee H.L. Systematical evaluation of the effects of sample collection procedures on low-molecular-weight serum/plasma proteome profiling. Proteomics 6 (2006) 3189-3198
41. Yi J.Z., Kim C., and Gelfand C.A. Inhibition of intrinsic proteolytic activities moderates preanalytical variability and instability of human plasma. J Proteome Res 6 (2007) 1768-1781
42. Engwegen J., Alberts M., Knol J.C., Jimenez C.R., Depla A., Tuynman H., et al. Influence of variations in sample handling on SELDI-TOF MS serum protein profiles for colorectal cancer. Proteom Clin Appl 2 (2008) 936-945